Authors
Muzammeel Hada, Iyad Mansour, Muna Omar, Bijin Thajudeen, Issa Yousef Batarseh, Sanjeeva Weerasinghe, Tahsin Ozpolat
Published in
Case reports in nephrology. Volume 2026. Pages 7595496. Epub Nov 15, 2026.
Abstract
Nontuberculous mycobacterial (NTM) infections are increasingly recognized as triggers of antineutrophil cytoplasmic antibody (ANCA) positivity and secondary ANCA-associated vasculitis. Differentiating infection-associated ANCA disease from primary AAV is critical because management and outcomes differ. This case describes an uncommon organism triggering MPO-ANCA glomerulonephritis and a management approach that avoided cytotoxic agents.
A 57-year-old woman with chronic pulmonary disease presented with acute kidney injury, glomerular-pattern (dysmorphic) microscopic hematuria, proteinuria, and MPO-ANCA positivity. Kidney biopsy demonstrated pauci-immune necrotizing and crescentic glomerulonephritis with marked chronicity (∼70% globally sclerosed glomeruli). Evaluation revealed pulmonary infection with multidrug-resistant Mycobacterium abscessus complex. Given active infection, cyclophosphamide and rituximab were withheld. The patient received pulse intravenous methylprednisolone followed by oral prednisone with targeted antimicrobial therapy.
Over approximately 6 months of follow-up, serum creatinine improved from a peak of 3.9 mg/dL to 2.2 mg/dL and subsequently to 1.9 mg/dL, ESR and CRP normalized from peaks of 102 mm/h and 68 mg/L, hematuria resolved, and proteinuria decreased. Quantitative MPO-ANCA, elevated at presentation, showed a progressive downtrend but remained detectable at last follow-up. The renal course is best characterized as stabilization with partial improvement on a background of advanced chronic damage.
This case highlights M. abscessus as a rare trigger of infection-associated MPO-ANCA glomerulonephritis and demonstrates that antimicrobial therapy combined with corticosteroids, without cytotoxic agents, can achieve renal stabilization and partial improvement. A downtrending MPO-ANCA titer, rather than a static one, is the serologic pattern most consistent with a resolving infection-associated process. Recognition of infection-driven ANCA disease is essential to avoid potentially harmful cytotoxic therapy during active infection.
PMID:
43036559
Bibliographic data and abstract were imported from PubMed on 16 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 6
- Comments 0